drugset / Trial / NCT03620890

Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy

NCT03620890

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether use of detemir compared to neutral protamine hagedorn (NPH) decreases rates of composite neonatal outcome and maternal hypoglycemia events in women with Type 2 Diabetes Mellitus (T2DM).

Timeline

Start
2018-09-04
Primary completion
2020-07-29
Completion
2020-07-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neutral Protamine Hagedorn Unknown Other
Comparator insulin detemir Protein / enzyme biologic